ZA966545B - Hormone medicaments and their use for correction of oestrogen deficiencies - Google Patents

Hormone medicaments and their use for correction of oestrogen deficiencies

Info

Publication number
ZA966545B
ZA966545B ZA966545A ZA966545A ZA966545B ZA 966545 B ZA966545 B ZA 966545B ZA 966545 A ZA966545 A ZA 966545A ZA 966545 A ZA966545 A ZA 966545A ZA 966545 B ZA966545 B ZA 966545B
Authority
ZA
South Africa
Prior art keywords
correction
oestrogen deficiencies
hormone medicaments
medicaments
hormone
Prior art date
Application number
ZA966545A
Other languages
English (en)
Inventor
Michel Lanquetin
Jean-Louis Thomas
Jacques Paris
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9481610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA966545(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Publication of ZA966545B publication Critical patent/ZA966545B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA966545A 1995-08-01 1996-08-01 Hormone medicaments and their use for correction of oestrogen deficiencies ZA966545B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509364A FR2737411B1 (fr) 1995-08-01 1995-08-01 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques

Publications (1)

Publication Number Publication Date
ZA966545B true ZA966545B (en) 1997-05-08

Family

ID=9481610

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA966545A ZA966545B (en) 1995-08-01 1996-08-01 Hormone medicaments and their use for correction of oestrogen deficiencies

Country Status (30)

Country Link
US (1) US5891867A (cs)
EP (1) EP0783310B1 (cs)
JP (1) JPH10507207A (cs)
KR (1) KR100450649B1 (cs)
CN (1) CN1138547C (cs)
AP (1) AP829A (cs)
AR (1) AR004502A1 (cs)
AT (1) ATE225659T1 (cs)
AU (1) AU722355B2 (cs)
BR (1) BR9606549A (cs)
CA (1) CA2201368C (cs)
CZ (1) CZ289706B6 (cs)
DE (1) DE69624214T2 (cs)
DK (1) DK0783310T3 (cs)
DZ (1) DZ2078A1 (cs)
ES (1) ES2184880T3 (cs)
FR (1) FR2737411B1 (cs)
HU (1) HU229843B1 (cs)
IL (1) IL120558A (cs)
MA (1) MA23946A1 (cs)
MX (1) MX9702381A (cs)
MY (1) MY117307A (cs)
NO (1) NO312996B1 (cs)
OA (1) OA10411A (cs)
PT (1) PT783310E (cs)
RU (1) RU2188641C2 (cs)
TN (1) TNSN96101A1 (cs)
TW (1) TW473390B (cs)
WO (1) WO1997004784A1 (cs)
ZA (1) ZA966545B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
US20020151732A1 (en) * 2001-01-05 2002-10-17 Claes Ohlsson Estrogen receptors
EP1390038A2 (en) 2001-05-16 2004-02-25 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
NZ591627A (en) * 2001-12-05 2012-09-28 Teva Womens Health Inc Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
AR065816A1 (es) * 2007-03-26 2009-07-01 Theramex Regimen anticonceptivo oral

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4870066A (en) * 1986-08-11 1989-09-26 The University Of Kentucky Research Foundation Method and composition for safely delaying parturition and synchronizing farrowing in swine
EP0483077B1 (en) * 1990-09-28 1995-12-06 I.F.L.O. S.a.s. di Giorgio e Aldo Laguzzi A method for carrying out the synthesis of a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic, preventive and therapeutic properties for treatment of mammary tumours and melanomas.
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Also Published As

Publication number Publication date
PT783310E (pt) 2003-02-28
ATE225659T1 (de) 2002-10-15
NO312996B1 (no) 2002-07-29
CZ96797A3 (cs) 1998-08-12
NO971449D0 (no) 1997-03-26
MY117307A (en) 2004-06-30
AU722355B2 (en) 2000-07-27
HUP9900612A3 (en) 1999-11-29
DE69624214D1 (de) 2002-11-14
TNSN96101A1 (fr) 2005-03-15
ES2184880T3 (es) 2003-04-16
IL120558A0 (en) 1997-07-13
IL120558A (en) 2002-09-12
CZ289706B6 (cs) 2002-03-13
EP0783310A1 (fr) 1997-07-16
OA10411A (fr) 2001-12-06
AP829A (en) 2000-05-03
FR2737411B1 (fr) 1997-10-17
DE69624214T2 (de) 2003-07-10
HUP9900612A2 (hu) 1999-07-28
AR004502A1 (es) 1998-12-16
AU6367496A (en) 1997-02-26
KR970706004A (ko) 1997-11-03
HU229843B1 (en) 2014-09-29
DK0783310T3 (da) 2003-02-10
CA2201368C (fr) 2010-12-07
DZ2078A1 (fr) 2002-10-22
WO1997004784A1 (fr) 1997-02-13
MX9702381A (es) 1998-02-28
CN1167438A (zh) 1997-12-10
MA23946A1 (fr) 1997-04-01
NO971449L (no) 1997-05-30
JPH10507207A (ja) 1998-07-14
CA2201368A1 (fr) 1997-02-13
BR9606549A (pt) 1998-06-23
HK1005227A1 (en) 1998-12-31
RU2188641C2 (ru) 2002-09-10
TW473390B (en) 2002-01-21
FR2737411A1 (fr) 1997-02-07
AP9700979A0 (en) 1997-07-31
KR100450649B1 (ko) 2004-11-16
US5891867A (en) 1999-04-06
EP0783310B1 (fr) 2002-10-09
CN1138547C (zh) 2004-02-18

Similar Documents

Publication Publication Date Title
EP0767685A4 (en) STENT AND THERAPEUTIC ADMINISTRATION SYSTEM
HUP9802608A3 (en) Hormone replacement therapy method and hormone dispenser
HUP9801230A3 (en) Benzopyran-derivatives and their use for the production of medicaments for treating estrogen sensitive diseases
IL113249A0 (en) Permanently ionic derivatives of steroid hormones and their antogonists
PL312064A1 (en) Soft gelatinous form of pharmaceutical dose
AU5343394A (en) Orthosis and prosthesis
AP9701092A0 (en) Use of fumagilol and derivateves thereof for preparing medicaments against intestinal infections
NZ321576A (en) 6-imidazol-1-ylmethyl-2-oxo-quinoline derivatives and medicaments
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
EP0711572A4 (en) INHALATOR AND METHOD FOR USE THEREOF
HUP9901089A3 (en) Medical splint
IL122215A0 (en) Dolastatin derivatives their preparation and use
EP0855873A4 (en) CONDOM CATHETER AND SUPPORT DEVICES
HUP9900612A3 (en) Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies
IL116590A0 (en) 3-phenylisoquinol-1(2h)-one derivatives their preparation and their therapeutic application
PL332610A1 (en) Hormonal preparation consisting of an oestrogen compound and of a progesterone compound
ZA952983B (en) Boronic peptide derivatives preparation and therapeutic application thereof
AU1942995A (en) New use of growth hormone
HUP9801158A3 (en) Imidazole derivatives and medicinal composition thereof
ZA968230B (en) Administration of biologically active material
AU2587195A (en) Growth hormone therapy and related methods and pharmaceutical compositions
AU6318896A (en) Benzamidoxime derivatives and medicinal use thereof
IL116532A0 (en) 1-oxo-2-(phenylsulphonylamino) pentylpiperdine derivatives their preparation and their therapeutic application
HU9402816D0 (en) Medicament for the treatment of airways inflammation and airways hyperresponsiveness
AU6406098A (en) Use of minalcipran and its derivatives for preparing a medicine for treating certain psychiatric diseases